Neobavaisoflavone sensitizes apoptosis via the inhibition of metastasis in TRAIL-resistant human glioma U373MG cells

Life Sciences

Volumn 95, Issue 2, 2014, Pages 101-107

  Kim, Young Joo ^a   Choi, Won Il ^d   Ko, Hyeonseok ^c   So, Youngsin ^b   Kang, Ki Sung ^a   Kim, Inki ^b   Kim, Kunhong ^d   Yoon, Ho Geun ^d   Kim, Tae Jin ^c   Choi, Kyung Chul ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Catholic Kwandong University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Anoikis; Apoptosis; Glioma; Metastasis; Neobavaisoflavone; TRAIL

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; ISOFLAVONE; NEOBAVAISOFLAVONE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANOIKIS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL STRAIN U373MG; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; METASTASIS; MOLECULARLY TARGETED THERAPY; PROTEIN EXPRESSION;

CULLEN CORYLIFOLIA; FABACEAE;

ANOIKIS; APOPTOSIS; GLIOMA; METASTASIS; NEOBAVAISOFLAVONE; TRAIL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GLIOMA; HUMANS; ISOFLAVONES; NEOPLASM METASTASIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 84892818305     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.10.035     Document Type: Article

References (23)

1. E. Bossy-Wetzel, and D.R. Green Caspases induce cytochrome c release from mitochondria by activating cytosolic factors J Biol Chem 274 1999 17484 17490
2. M.J. Don, L.C. Lin, and W.F. Chiou Neobavaisoflavone stimulates osteogenesis via p38-mediated up-regulation of transcription factors and osteoid genes expression in MC3T3-E1 cells Phytomedicine 19 2012 551 561
3. T.M. Ganten, T.L. Haas, J. Sykora, H. Stahl, M.R. Sprick, and S.C. Fas et al. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs Cell Death Differ 11 Suppl. 1 2004 S86 S96
4. G.S. Goldberg, Z. Jin, H. Ichikawa, A. Naito, M. Ohki, and W.S. El-Deiry et al. Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis Cancer Res 61 2001 1334 1337
5. C.J. Hawkins TRAIL and malignant glioma Vitam Horm 67 2004 427 452
6. J. Jadlowiec, H. Koch, X. Zhang, P.G. Campbell, M. Seyedain, and C. Sfeir Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway J Biol Chem 279 2004 53323 53330
7. Y. Kim, and D.W. Seol TRAIL, a mighty apoptosis inducer Mol Cells 15 2003 283 293
8. F.C. Kischkel, D.A. Lawrence, A. Chuntharapai, P. Schow, K.J. Kim, and A. Ashkenazi Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 12 2000 611 620
9. M.J. Knight, C.D. Riffkin, A.M. Muscat, D.M. Ashley, and C.J. Hawkins Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells Oncogene 20 2001 5789 5798
10. M. Lauricella, A. Ciraolo, D. Carlisi, R. Vento, and G. Tesoriere SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells Biochimie 94 2012 287 299
11. H.N. LeBlanc, and A. Ashkenazi Apo2L/TRAIL and its death and decoy receptors Cell Death Differ 10 2003 66 75
12. F.R.S. Lima, S.A. Kahn, R.C. Soletti, D. Biasoli, T. Alves, and A.C.C. da Fonseca et al. Glioblastoma: therapeutic challenges, what lies ahead BBA Rev Cancer 1826 2012 338 349
13. N. Mitsiades, V. Poulaki, C. Mitsiades, and M. Tsokos Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5 Cancer Res 61 2001 2704 2712
14. G. Pan, K. O'Rourke, A.M. Chinnaiyan, R. Gentz, R. Ebner, and J. Ni et al. The receptor for the cytotoxic ligand TRAIL Science 276 1997 111 113
15. S.J. Park, M.J. Kim, H.B. Kim, H.Y. Sohn, J.H. Bae, and C.D. Kang et al. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells Exp Cell Res 315 2009 1809 1818
16. S.J. Park, S.H. Park, J.O. Kim, J.H. Kim, S.J. Park, and J.J. Hwang et al. Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax Biochem Biophys Res Commun 428 2012 185 190
17. S.M. Srinivasula, R. Hegde, A. Saleh, P. Datta, E. Shiozaki, and J. Chai et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis Nature 410 2001 112 116
18. E. Szliszka, K.J. Helewski, E. Mizgala, and W. Krol The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells Int J Oncol 39 2011 771 779
19. E. Szliszka, D. Skaba, Z.P. Czuba, and W. Krol Inhibition of inflammatory mediators by neobavaisoflavone in activated RAW264.7 macrophages Molecules 16 2011 3701 3712
20. E. Szliszka, G. Zydowicz, E. Mizgala, and W. Krol Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis Int J Oncol 41 2012 818 828
21. L. Wang, H.J. Chun, W. Wong, D.M. Spencer, and M.J. Lenardo Caspase-10 is an initiator caspase in death receptor signaling Proc Natl Acad Sci U S A 98 2001 13884 13888
22. M.J. Yoon, Y.J. Kang, I.Y. Kim, E.H. Kim, J.A. Lee, and J.H. Lim et al. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation Carcinogenesis 34 2013 1918 1928
23. M. You, N. Savaraj, M. Wangpaichitr, C. Wu, M.T. Kuo, and J. Varona-Santos et al. The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines Biochem Biophys Res Commun 394 2010 760 766